{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:24:54Z","timestamp":1790796294249,"version":"4.1.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Pituitary hormone axes modulate glucose metabolism and exert direct or indirect effects on insulin secretion and function. Cortisol and growth hormone are potent insulin-antagonistic hormones. Therefore impaired glucose tolerance, elevated fasting glucose concentrations and diabetes mellitus are frequent in Cushing\u2019s disease and acromegaly. Also prolactinomas, growth hormone (GH) deficiency, hypogonadism and hypothyroidism might be associated with impaired glucose homeostasis but usually to a lesser extent. Therefore glucose metabolism needs to be closely monitored and treated in patients with pituitary adenomas. Correction of the pituitary dysfunction is frequently followed by improvement of glucose homeostasis.<\/jats:p>","DOI":"10.3389\/fendo.2021.626427","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T04:52:34Z","timestamp":1619585554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["The Interaction of Insulin and Pituitary Hormone Syndromes"],"prefix":"10.3389","volume":"12","author":[{"given":"Marie Helene","family":"Schernthaner-Reiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greisa","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"B1","article-title":"XI. Diagnosis and treatment of co-morbidities in pituitary tumors. 45. Metabolic disorders","volume-title":"Pituitary Tumors: A Comprehensive and Interdisciplinary Approach","author":"Schernthaner-Reiter","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic Comorbidities in Cushing\u2019s Syndrome","volume":"173","author":"Ferrau","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1050","article-title":"Diabetes in Acromegaly, Prevalence, Risk Factors, and Evolution: Data From the French Acromegaly Registry","volume":"164","author":"Fieffe","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.881696","article-title":"Diabetic Ketoacidosis Associated With Adrenocorticotropic Hormone-Producing Pituitary Adenoma","volume":"12","author":"Sugino","year":"2011","journal-title":"Am J Case Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0060","article-title":"Ketoacidosis as the Initial Clinical Condition in Nine Patients With Acromegaly: A Review of 860 Cases At a Single Institute","volume":"169","author":"Yoshida","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4158\/EP12247.OR","article-title":"Persistance of Cushing\u2019s Disease Symptoms and Comorbidities After Surgical Cure: A Long-Term, Integral Evaluation","volume":"19","author":"Espinosa-de-los-Monteros","year":"2013","journal-title":"Endocr Pract"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1819-6","article-title":"Factors Predicting Long-Term Comorbidities in Patients With Cushing\u2019s Syndrome in Remission","volume":"64","author":"Schernthaner-Reiter","year":"2019","journal-title":"Endocrine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12.Month Phase 3 Study of Pasireotide in Cushing\u2019s Disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1210\/er.2016-1105","article-title":"Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management","volume":"38","author":"Scaroni","year":"2017","journal-title":"Endocr Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1095","article-title":"The Burden of Cushing\u2019s Disease: Clinical and Health-Related Quality of Life Aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and Mortality in Cushing\u2019s Disease: An Epidemiological Approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1563-2571.2000.00106.x","article-title":"Diabetes-H\u00e4ufigkeit Bei Akromegalie Und Cushing-Syndrom","volume":"27","author":"Biering","year":"2000","journal-title":"Acta Med Austriaca"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021518","article-title":"Cavagnini and the Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of Endocrinology. Gender-Related Differences in the Presentation and Course of Cushing\u2019s Disease","volume":"88","author":"Pecori Giraldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing\u2019s Syndrome: 2-Year Experience. Baseline Demographic and Clinical Characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12299","article-title":"Diagnosis and Complications of Cushing\u2019s Disease: Gender-Related Differences","volume":"80","author":"Zilio","year":"2014","journal-title":"Clin Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4158\/EP14284.CR","article-title":"An Unusual Presentation of Pediatric Cushing Disease: Diabetic Ketoacidosis","volume":"1","author":"Catli","year":"2015","journal-title":"AACE Clin Case Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1530\/EDM-16-0123","article-title":"Case of Diabetic Ketoacidosis as an Initial Presentation of Cushing\u2019s Syndrome","volume":"2017","author":"Acharya","year":"2017","journal-title":"Endocrinol Diabetes Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030254","article-title":"Occult Cushing\u2019s Syndrome in Type 2 Diabetes","volume":"88","author":"Catargi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1055\/a-0809-3647","article-title":"Hypercortisolism in Newly Diagnosed Type 2 Diabetes: A Prospective Study in 384 Newly Diagnosed Patients","volume":"51","author":"Steffensen","year":"2019","journal-title":"Horm Metab Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2006.04.010","article-title":"Hypothalamic-Pituitary-Adrenal Activity in Type 2 Diabetes Mellitus: Role of Autonomic Imbalance","volume":"55","author":"Chiodini","year":"2006","journal-title":"Metab Clin Exp"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2012.455","article-title":"The Investigation of Cushing Syndrome: Essentials in Optimizing Appropriate Diagnosis and Management","volume":"32","author":"Juszczak","year":"2012","journal-title":"Ann Saudi Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients With Cushing\u2019s Disease During Active Disease and 1 Year After Disease Remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and Cardiovascular Outcomes in Patients With Cushing\u2019s Syndrome of Different Aetiologies During Active Disease and 1 Year After Remission","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14081","article-title":"Long-Term Efficacy and Safety of Once-Monthly Pasireotide in Cushing\u2019s Disease: A Phase III Extension Study","volume":"91","author":"Fleseriu","year":"2019","journal-title":"Clin Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-016-1029-z","article-title":"Hyperglycemia in Pasireotide-Treated Patients With Acromegaly and its Treatment","volume":"54","author":"Luger","year":"2016","journal-title":"Endocrine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1771","article-title":"Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers","volume":"98","author":"Henry","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3350","article-title":"Cross C. Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients With Cushing\u2019s Syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0404-6","article-title":"Italian Society for the Study of Diabetes (Sid)\/Italian Endocrinological Society (SIE)Guidelines on the Treatment of Hyperglycemia in Cushing\u2019s Syndrome and Acromegaly","volume":"39","author":"Baroni","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1210\/jc.2009-1385","article-title":"Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients With Type 2 Diabetes Mellitus","volume":"95","author":"Habib","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1884","article-title":"SGLT2 Inhibitors may Predispose to Ketoacidosis","volume":"100","author":"Taylor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-955096","article-title":"Preserved GLP-1 Effect in a Diabetic Patient With Cushing\u2019s Disease","volume":"115","author":"Ritzel","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/er.2008-0027","article-title":"Effects of Growth Hormone on Glucose, Lipid and Protein Metabolism in Human Subjects","volume":"30","author":"Moeller","year":"2009","journal-title":"Endocr Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1210974","article-title":"Decreased Peripheral Insulin Sensitivity in Acromegalic Patients","volume":"95","author":"Luger","year":"1990","journal-title":"Exp Clin Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00509","article-title":"Insulin Resitance in Patients With Acromegaly","volume":"10","author":"Vila","year":"2019","journal-title":"Front Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0271","article-title":"IGF-I Treatment of Insulin Resistance","volume":"157","author":"McDonald","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02281","article-title":"Pegvisomant Improves Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies","volume":"104","author":"Feola","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-010-0284-x","article-title":"Clinical and Biochemical Characteristics of Acromegalic Patients With Different Abnormalities in Glucose Metabolism","volume":"14","author":"Espinosa-de-los-Monteros","year":"2011","journal-title":"Pituitary"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2896","article-title":"The Metabolic Profile in Active Acromegaly is Gender-Specific","volume":"98","author":"Ciresi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0471-7","article-title":"Prevalence and Risk Factors of Impaired Glucosetolerance and Diabetes Mellitus At Diagnosis of Acromegaly: A Study in 148 Patients","volume":"17","author":"Alexopoulou","year":"2014","journal-title":"Pituitary"},{"key":"B40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/EJE-07-0358","article-title":"AcroBel \u2013 the Belgian Registry on Acromegaly: A Survey of the \u2018Real-Life\u2019 Outcome in 418 Acromegalic Subjects","volume":"157","author":"Bex","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly At Diagnosis in 3173 Patients From the Liege Acromegaly Survey (Las) Database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly Incidence, Prevalence, Complications and Long-Term Prognosis: A Nationwide Cohort Study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.72.853.682","article-title":"Acromegaly Presenting With Diabetic Ketoacidosis","volume":"72","author":"Katz","year":"1996","journal-title":"Postgrad Med J"},{"key":"B44","article-title":"Concurrent Diagnosis of Acromegaly and Diabetic Ketoacidosis","volume":"6","author":"Westphal","year":"2000","journal-title":"Endocr Pract"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(08)60042-X","article-title":"Diabetic Ketoacidosis in a Patient With Acromegaly","volume":"106","author":"Chen","year":"2007","journal-title":"J Formos Med Assoc"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2337\/diaclin.30.4.170","article-title":"Diabetic Ketoacidosis as a Presenting Feature of Acromegaly: When Excess Hormone Meets Hormone Deficiency","volume":"30","author":"Simmons","year":"2012","journal-title":"Clin Diabetes"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1096","article-title":"Impaired Glucose Metabolism in Japanese Patients With Acromegaly is Restored After Successful Pituitary Surgery If Pancreatic \u03b2-Cell Function is Preserved","volume":"164","author":"Kinoshita","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00325","article-title":"Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly","volume":"103","author":"Gonzalez","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/BF00186626","article-title":"Bromocriptine Treatment Over 12 Years in Acromegaly: Effect on Glucose Tolerance and Insulin Secretion","volume":"71","author":"Rau","year":"1993","journal-title":"Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12307","article-title":"Different Effects of Cabergoline and Bromocriptine on Metabolic and Cardiovascular Risk Factors in Patients With Elevated Prolactin Levels","volume":"116","author":"Krysiak","year":"2015","journal-title":"Basic Clin Pharmacol Toxicolol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02566","article-title":"Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies","volume":"103","author":"Cozzolino","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0895-8","article-title":"Effect of Pasireotide on Glucose- and Growth Hormone-Related Biomarkers in Patients With Inadequately Controlled Acromegaly","volume":"53","author":"Schmid","year":"2016","journal-title":"Endocrine"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz096","article-title":"A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update","volume":"105","author":"Giustina","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00082","article-title":"Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly","volume":"102","author":"Quarella","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000188","article-title":"Insulin Signaling in the Whole Spectrum of GH Deficiency","volume":"63","author":"Mendes Garmes","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2000.00695.x","article-title":"The Increased Insulin Sensitivity in Growth Hormone-Deficient Adults is Reduced by Growth Hormone Replacement Therapy","volume":"30","author":"Riedl","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.2.8636267","article-title":"Insulin Resistance in Growth Hormone Deficient Adults: Defects in Glucose Utilization and Glycogen Synthase Activity","volume":"81","author":"Hew","year":"1996","journal-title":"J Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/EJE-12-0807","article-title":"Prevalence of Diabetes Mellitus in 6050 Hipuitary Patients With Adult-Onset GH Deficiency Before GH Replacement: A KIMS Analysis","volume":"168","author":"Abs","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/BF00273860","article-title":"Severe Hyperprolactinaemia is Associated With Decreased Insulin Binding In Vitro and Insulin Resistance In Vivo","volume":"28","author":"Schernthaner","year":"1985","journal-title":"Diabetologia"},{"key":"B60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000357810","article-title":"Effect of Cabergoline on Metabolism in Prolactinomas","volume":"98","author":"Auriemma","year":"2013","journal-title":"Neuroendocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00403.x","article-title":"Increased Body Weight Associated With Prolactin Secreting Pituitary Adenomas: Weight Loss With Normalization of Prolactin Levels","volume":"48","author":"Greenman","year":"1998","journal-title":"Clin Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00771","article-title":"Novel Trajectories of Bromocriptine Antidiabetic Action: leptin-IL6\/JAK2\/p-STAT3\/SOCS3, p-IR\/p-AKT\/GLUT4, Ppar-\u03b3\/Adiponectin, Nrf2\/PARP-1, and GLP-1","volume":"9","author":"Reda","year":"2018","journal-title":"Front Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0442","article-title":"Prolactin\/Leptin Interactions in the Control of Food Intake in Rats","volume":"148","author":"Naef","year":"2007","journal-title":"Endocrinology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-0487","article-title":"Ben-Jonathan. The Prolactin-Deficient Mouse has an Unaltered Metabolic Phenotype","volume":"147","author":"LaPensee","year":"2006","journal-title":"Endocrinology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1210\/en.2016-1444","article-title":"Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males","volume":"158","author":"Ruiz-Herrera","year":"2017","journal-title":"Endocrinology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1579","article-title":"Androgens and Diabetes in Men. Results From the Third National Health and Nutrition Survey (Nhanes Iii","volume":"30","author":"Selvin","year":"2007","journal-title":"Diabetes Care"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01991.x","article-title":"Testosterone and Metabolic Syndrome: A Meta-Analysis Study","volume":"8","author":"Corona","year":"2011","journal-title":"J Sex Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030242","article-title":"The Emergence of the Metabolic Syndrome With Menopause","volume":"88","author":"Carr","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of Oestrogen Plus Progestin on the Incidence of Diabetes in Postmenopausal Women: Results From the Women\u2019s Health Initiative Hormone Trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.122","article-title":"Testosterone and Insulin Resistance in the Metabolic Syndrome and T2DM in Men","volume":"9","author":"Rao","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-13-0393","article-title":"Testosterone and Glucose Metabolism in Men: Current Concepts and Controversies","volume":"220","author":"Grossmann","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2337\/db18-0638","article-title":"Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis Via the Transcription Factor Foxo1","volume":"68","author":"Yan","year":"2019","journal-title":"Diabetes"},{"key":"B73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/cells10010099","article-title":"Estrogen and Glycemic Homeostasis: The Fundamental Role of Nuclear Estrogen Receptors ESR1\/ESR2 in Glucose Transporter GLUT4 Regulation","volume":"10","author":"Gregorio","year":"2021","journal-title":"Cells"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1210\/er.2012-1055","article-title":"The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis","volume":"34","author":"Mauvais-Jarvis","year":"2013","journal-title":"Endocr Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2005.121","article-title":"Insulin Sensitivity and Counter-Regulatory Hormones in Hypothyroidism and During Thyroid Hormone Replacement Therapy","volume":"43","author":"Stanicka","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12916-016-0693-4","article-title":"Thyroid Function and Risk of Type 2 Diabetes: A Population-Based Prospective Cohort Study","volume":"14","author":"Chaker","year":"2016","journal-title":"BMC Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2042018820917869","article-title":"The Role of Thyroid Hormone in Metabolism and Metabolic Syndrome","volume":"11","author":"De Fatima dos Santos Teixeira","year":"2020","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.626427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T04:52:38Z","timestamp":1619585558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.626427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":77,"alternative-id":["10.3389\/fendo.2021.626427"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.626427","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"article-number":"626427"}}